SALE: Up to 50% OFF including all GLPs + Buy 2 Get 1 FREE

Free Reconstitution Solution Nashville,TN | USA Lab Tested Same Day FREE shipping
Free Reconstitution Solution Nashville, TN | USA Lab Tested Same Day FREE Shipping

KLOW 80MG Research Peptide Blend

Categories:

• Components: TB-500 10mg + BPC-157 10mg + KPV 10mg + GHK-Cu 50mg
• Total Weight: 80mg
• CAS Numbers: 107761-42-2 / 137525-51-0 / 35115-60-7 / 49557-75-7
• Synonyms: Recovery & Regeneration Peptide Blend; KLOW Stack

$109.00

Availability: 84 in stock (can be backordered)

BUY 2 GET 1

Buy 2 Get 1 Free – Auto added to cart

- +
4.9 (1,247 reviews)
Money Back Guarantee 30-day return policy
99%+ Purity Guaranteed 3rd party USA lab tested — COA included
FREE Same Day Shipping Order by 12pm Mon–Fri for same-day dispatch
Secure SSL Checkout Data protection at every step
Real Human Support Text or email — Nashville, TN team

Availability: 84 in stock (can be backordered)

BUY 2 GET 1

Buy 2 Get 1 Free – Auto added to cart

- +
4.9 (1,247 reviews)
Money Back Guarantee 30-day return policy
99%+ Purity Guaranteed 3rd party USA lab tested — COA included
FREE Same Day Shipping Order by 12pm Mon–Fri for same-day dispatch
Secure SSL Checkout Data protection at every step
Real Human Support Text or email — Nashville, TN team

⚠️ RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

FD

Freedom Diagnostics

Freedom Diagnostics - Proudly Owned and Operated in the USA.

Certificate of analysis

99.73%

Purity by HPLC-UV; identity by LC-MS

Lot
KLOW - 6844
Tested
Sep 4, 2026
Labeled
Klow 80mg
Measured
GHK-Cu 57.92 mg; KPV 12.86 mg; BPC-157 12.16 mg; Thymosin Beta-4 10.17 mg
Leave blank - no ISO/accreditation badge is shown on the supplied COA.6 tests recorded
View certificate (PDF)(opens in a new tab)

QC panel

3 passed · 3 reported
IdentityLC-MS
GHK-Cu/KPV/Thymosin Beta-4/BPC-157Reported
PurityHPLC-UV
99.73%Reported
Net Contentas reported on COA
GHK-Cu 57.92 mg; KPV 12.86 mg; BPC-157 12.16 mg; Thymosin Beta-4 10.17 mgReported
EndotoxinLAL assay / USP
PassPass
Microbial AnalysisPCR
No Detectable Microbial DNAPass
Elemental ImpuritiesICP-MS; As/Cd/Pb/Hg below reporting/specification limits
PassPass

Every batch on record

Inspect a batch’s results or open its original certificate.

KLOW Blend 80mg 80mg

Latest

Lot KLOW - 6844

99.73%Purity by HPLC-UV; identity by LC-MS
Labeled
Klow 80mg
Measured
GHK-Cu 57.92 mg; KPV 12.86 mg; BPC-157 12.16 mg; Thymosin Beta-4 10.17 mg
Identity
GHK-Cu/KPV/Thymosin Beta-4/BPC-157
Endotoxin
Pass
Microbial Analysis
No Detectable Microbial DNA
Elemental Impurities
Pass
Tested
Sep 4, 2026

Identity confirmed; purity 99.73%; net content GHK-Cu 57.92 mg; KPV 12.86 mg; BPC-157 12.16 mg; Thymosin Beta-4 10.17 mg; endotoxin, microbial PCR, and elemental impurities passed. · Freedom Diagnostics · Leave blank - no ISO/accreditation badge is shown on the supplied COA.

View certificate(opens in a new tab)

KLOW Blend 80mg 80mg

Latest

Lot 4299

99.857%Purity by HPLC-UV; identity by LC-MS
Labeled
Klow 80mg
Measured
GHK-Cu 58.65 mg; KPV 9.23 mg; BPC-157 9.42 mg; Thymosin Beta-4 8.96 mg
Identity
GHK-Cu/KPV/BPC-157/Thymosin Beta-4
Tested
Apr 5, 2026

Identity GHK-Cu/KPV/BPC-157/Thymosin Beta-4; purity 99.857%; net content GHK-Cu 58.65 mg; KPV 9.23 mg; BPC-157 9.42 mg; Thymosin Beta-4 8.96 mg. · Freedom Diagnostics · Leave blank - no ISO/accreditation badge is shown on the supplied COA.

View certificate(opens in a new tab)

KLOW 80MG is a defined research peptide blend containing GHK-Cu 50mg, TB-500 10mg, BPC-157 10mg, and KPV 10mg in a single lyophilized vial. The formulation is intended for qualified laboratory research involving peptide interactions, cellular signaling, extracellular matrix biology, molecular pathways, and comparative studies.

With four individually identified components and a total peptide content of 80mg, KLOW provides researchers with a standardized formulation for controlled experimental workflows. The defined composition also supports straightforward laboratory inventory management and batch documentation.

KLOW 80MG composition

Each vial contains:

  • GHK-Cu: 50mg
  • TB-500: 10mg
  • BPC-157: 10mg
  • KPV: 10mg
  • Total peptide content: 80mg
  • Form: Lyophilized powder

Each component has a distinct molecular identity and research profile, allowing laboratories to investigate the blend within experimental models that involve multiple peptide pathways.

Research overview

KLOW brings together four peptides that have been independently studied across different areas of peptide and cellular research.

GHK-Cu is a copper-binding peptide investigated in research involving extracellular matrix biology, collagen-related pathways, fibroblast activity, and cellular signaling.

TB-500 is a synthetic peptide fragment associated with research into actin-related processes, cellular movement, cytoskeletal organization, and vascular signaling models.

BPC-157 is a synthetic peptide investigated in experimental research involving cellular communication, connective tissue biology, vascular pathways, and tissue-related models.

KPV is the tripeptide sequence Lysine-Proline-Valine and is associated with α-MSH-related research. Laboratory investigations have examined KPV in models involving cellular signaling, inflammatory pathways, epithelial biology, and molecular communication.

The combination provides a convenient format for researchers studying interactions between different peptide systems without needing to maintain four separate formulations for applicable experimental workflows.

Areas of scientific interest

KLOW 80MG may be incorporated into research involving:

  • Extracellular matrix biology
  • Collagen-related research
  • Fibroblast activity
  • Cellular communication
  • Cell migration models
  • Cytoskeletal pathways
  • Vascular signaling
  • Inflammatory pathway research
  • Epithelial biology
  • Connective tissue models
  • Peptide interaction studies
  • Comparative molecular research

These are areas of scientific investigation and should not be interpreted as claims regarding specific outcomes associated with the product.

Why choose KLOW 80MG?

Researchers working with multiple peptide compounds may find a defined blend useful when their experimental design requires several research materials in one formulation.

KLOW 80MG offers several practical research characteristics:

  • Four defined components: GHK-Cu, TB-500, BPC-157, and KPV are clearly identified.
  • Documented quantities: The formulation contains 50mg of GHK-Cu and 10mg each of the other three peptides.
  • 80mg total content: The total peptide quantity is clearly specified for laboratory records.
  • Lyophilized presentation: The dry formulation is suitable for controlled storage before applicable laboratory preparation.
  • Simplified inventory: A single vial can streamline material tracking when all four components are relevant to a research workflow.

Researchers should assess the suitability of the blend based on their own experimental requirements, analytical methods, and laboratory protocols.

KLOW peptide and metabolic research

Searches for KLOW peptide metabolism reflect interest in whether multi-peptide formulations can be examined across different biological pathways. KLOW itself contains components with distinct research profiles, so investigations involving metabolism should be designed around the specific pathway or molecular interaction being evaluated.

The blend should not be treated as having a single biological mechanism simply because its components are supplied together. Researchers should consider each peptide individually as well as the formulation as a whole when designing experimental studies.

KLOW peptide COA and batch documentation

A KLOW peptide COA can provide useful batch-specific information for laboratory records. Documentation is particularly relevant for a multi-component formulation because researchers may need to verify the product identity and composition associated with a particular batch.

Research documentation may include:

  • Product and batch identification
  • Component information
  • Stated purity data where applicable
  • Analytical results
  • Manufacturing information
  • Storage requirements

Laboratories requiring additional confirmation should use their own validated analytical procedures and acceptance criteria.

KLOW peptide procurement

Researchers searching to buy KLOW 80mg, KLOW peptide for sale, or KLOW buy online should review the complete product specifications and available batch documentation before procurement.

When comparing KLOW 80mg price, researchers may also consider the formulation’s total peptide content, individual component quantities, documentation, packaging, and current availability rather than evaluating cost alone.

For laboratories looking for a KLOW peptide supplier in the USA, product transparency and appropriate research documentation can be useful factors when evaluating potential suppliers.

Manufacturing and quality standards

KLOW 80MG is produced as a research compound with controlled manufacturing and handling procedures. Product quality considerations include peptide identity, formulation consistency, packaging, and applicable analytical verification.

Batch-specific documentation can help researchers maintain organized records and support traceability throughout a research project.

Product storage and care

KLOW 80MG is supplied as a lyophilized powder and requires reconstitution before applicable laboratory research procedures.

Store unopened vials in a cool, dry place away from direct light. Once reconstituted, keep refrigerated according to applicable laboratory storage procedures. For extended storage, -20°C is recommended where appropriate to help preserve peptide integrity.

Minimize exposure to excessive heat, moisture, and light. Repeated freeze-thaw cycles should also be avoided where possible.

RIVN Peptides does not provide dosing guidance, administration instructions, or directions outside laboratory research procedures. Researchers should follow their established laboratory SOPs and applicable product documentation for preparation and handling.

Product information

Specification Details
Product Name KLOW 80MG Research Blend
GHK-Cu 50mg
TB-500 10mg
BPC-157 10mg
KPV 10mg
Total Content 80mg
Form Lyophilized Powder
Category Research Peptides
Application Laboratory Research Only

Research use only

KLOW 80MG is supplied exclusively for scientific, analytical, and laboratory research. It is intended for qualified research environments and controlled experimental applications.

Researchers are responsible for following applicable institutional requirements, laboratory SOPs, and relevant regulations when handling, preparing, analyzing, storing, and disposing of research materials.

Frequently asked questions

What is KLOW 80MG?

KLOW 80MG is a defined research peptide blend containing GHK-Cu 50mg, TB-500 10mg, BPC-157 10mg, and KPV 10mg, supplied as a lyophilized powder.

What peptides are included in KLOW 80MG?

The formulation contains four components: GHK-Cu, TB-500, BPC-157, and KPV, with a total peptide content of 80mg.

What is KLOW 80MG studied for?

KLOW may be incorporated into laboratory research involving peptide signaling, extracellular matrix biology, cellular communication, connective tissue models, inflammatory pathways, and multi-peptide interactions.

What should researchers look for in a KLOW peptide COA?

A batch-specific COA may provide information such as product identification, component details, purity data, and analytical results. Researchers should review the documentation associated with their specific batch.

How should KLOW 80MG be stored?

Store the unopened lyophilized vial in a cool, dry place away from direct light. After reconstitution, refrigeration should follow applicable laboratory procedures. For extended storage, -20°C is recommended where appropriate to help maintain peptide integrity.

PDF preview is not available in this browser.

Open PDF Certificate

PDF preview is not available in this browser.

Open PDF Certificate

Related Products

Age Verification!

By clicking “I Agree & Enter”, you confirm the statements above and acknowledge responsibility for compliance with applicable laws and regulations.